Close Menu

OptiGene

The device, available for license from the Lawrence Livermore National Laboratories Industrial Partnerships Office, integrates a single-tube nucleic acid extraction method with loop-mediated isothermal amplification or reverse transcriptase LAMP.

OptiGene has licensed Eiken's loop-mediated isothermal amplification method to use in nucleic acid amplification reagents for infectious disease testing; while the UK's VLA has licensed the technology for veterinary testing and environmental monitoring.

OptiGene will develop, manufacture, and sell nucleic acid amplification reagents for research use, and VLA will develop, manufacture, and provide testing for nucleic acid diagnostics for veterinary purposes and environmental monitoring.

The platform will be based on isothermal amplification and its developers aim to cut the amount of time it takes to diagnose STDs to 15 minutes or less at the point of care.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.